IRIDEX Sees Prelim. Q4 Sales $11.6M-$11.8M vs $10.88M Est., Sees Prelim. FY19 Sales $43.3M-$43.5M vs $42.57M Est.

Total revenue for the fourth quarter of 2019 expected to be $11.6 - $11.8 million, compared to $11.5 million in the fourth quarter of 2018. Total revenue for 2019 expected to be $43.3 - $43.5 million, compared to

Benzinga · 01/13/2020 21:06
  • Total revenue for the fourth quarter of 2019 expected to be $11.6 - $11.8 million, compared to $11.5 million in the fourth quarter of 2018.
  • Total revenue for 2019 expected to be $43.3 - $43.5 million, compared to $42.6 million in 2018.
  • Shipped 13,500 - 13,900 G6 probes in the fourth quarter and 53,300 - 53,700 G6 probes in the full year 2019, delivering approximately 17% growth over fiscal year 2018.
  • Shipped 104 - 109 Cyclo G6® Glaucoma Laser Systems in the fourth quarter 2019, and 385 - 390 systems for fiscal year 2019.
  • Net cash and cash equivalents of approximately $12.6 million as of December 28, 2019, representing net cash burn of $0.3 million in the fourth quarter of 2019.